Kynam Capital Management, LP - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 83 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
Kynam Capital Management, LP ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$1,246,554
-25.4%
473,975
+0.2%
0.20%
-11.3%
Q2 2023$1,669,937
+14.2%
473,0700.0%0.23%
+21.7%
Q1 2023$1,461,786
-38.5%
473,070
-15.8%
0.19%
-48.1%
Q4 2022$2,375,606
+79.0%
561,609
+0.3%
0.36%
+30.0%
Q3 2022$1,327,000
-19.7%
559,769
-3.5%
0.28%
-33.6%
Q2 2022$1,653,000
-12.2%
579,915
-11.3%
0.42%
-30.8%
Q1 2022$1,882,000
-9.4%
653,445
-4.4%
0.61%
-45.1%
Q4 2021$2,078,000683,6191.11%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders